Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long term impact of the SARS-CoV2 pandemic on the acquisition rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a medical intensive care unit.

American journal of infection control·2025
Same author

Mailing Vaginal or Urine Self-Sampling Kits versus Conventional Invitation Letters: A Randomized Trial to Assess the Effect on Cervical Cancer Screening Attendance.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same author

No evidence of an effect of the M184I/V on the doravirine/lamivudine/tenofovir switch efficacy in people with HIV.

AIDS (London, England)·2025
Same author

Women's perceptions and preferences toward HPV self-sampling in France: A questionnaire within the French CapU4 Trial.

Journal of infection and public health·2025
Same author

Granuloma and persistent detection of wild-type rubella virus in an immunocompromised patient.

Microbiology spectrum·2025
Same author

Acceptance of Self-Sampling by Women Not Regularly Participating in Cervical Cancer Screening in Areas with Low Medical Density: A Qualitative Study within the French CapU4 Trial.

Cancers·2024

Related Experiment Video

Updated: Nov 16, 2025

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.5K

HCV virology and diagnosis.

Steven Roger1, Alexandra Ducancelle1, Hélène Le Guillou-Guillemette1

  • 1Laboratoire de Virologie, CHU Angers et Université d'Angers, Laboratoire HIFIH UFR Santé Département Médecine, SFR 4208-UPRES EA3859, BAT IBS - 4 rue Larrey, 49000 Angers, France.

Clinics and Research in Hepatology and Gastroenterology
|February 26, 2021
PubMed
Summary

Hepatitis C virus (HCV) infection causes severe liver disease, but new direct-acting antivirals offer a cure. A prophylactic vaccine is a priority, and understanding HCV virology and diagnostics is key to global eradication.

Keywords:
DiagnosisHepatitis C virusVirology

More Related Videos

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

1.7K
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.8K

Related Experiment Videos

Last Updated: Nov 16, 2025

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.5K
Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

1.7K
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.8K

Area of Science:

  • Hepatology and Virology
  • Public Health
  • Vaccinology

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern, causing chronic hepatitis, cirrhosis, and liver cancer, affecting millions worldwide.
  • Despite effective treatments like direct-acting antivirals (DAAs), a prophylactic vaccine is still needed for global eradication.
  • Underdiagnosis remains a major challenge, particularly in resource-limited settings, due to the cost of diagnostic tools and mild initial symptoms.

Purpose of the Study:

  • To review the virology and cell biology of Hepatitis C virus (HCV).
  • To discuss the current landscape of HCV treatments and the ongoing need for a vaccine.
  • To explore various laboratory tests used for diagnosing and monitoring HCV infection.

Main Methods:

  • Literature review of scientific publications on HCV.
  • Analysis of epidemiological data on HCV burden and mortality.
  • Discussion of advancements in HCV diagnostics and therapeutics.

Main Results:

  • HCV is a major cause of liver disease, with millions affected globally.
  • Direct-acting antivirals (DAAs) provide highly effective short-term treatment with minimal side effects.
  • A promising HBV-HCV vaccine candidate shows cross-neutralizing activity, but no vaccine is currently available.

Conclusions:

  • HCV can be effectively treated and eradicated with modern antivirals.
  • Developing a prophylactic HCV vaccine is a critical medical priority.
  • Improving diagnostic accessibility and awareness is essential for global HCV elimination efforts.